The European Commission has issued guidance on Europe’s patent system which rejects changes that many research organisations had warned could “devastate” R&D investment.
The guidance, published on 29 November, relates to ‘standard essential patents’, which cover innovations that must comply with an agreed technical standard.
Research and technology organisations and companies had warned that the Commission’s draft plans proposed changes that would have made it impossible to generate a return on the investments underlying such patents. Those plans would have required patent holders to grant a licence to any organisation that asked for one, which would have reduced their ability to set prices according to eventual use.